In parallel, PFD suppressed TGF-β-associated lipid accumulation in vitro, reduced SREBP1/FASN expression in activated HSC-rich regions in vivo, and alleviated CCl<sub>4</sub>-induced liver fibrosis. The gene discussed is SREBF1; the disease is polyostotic fibrous dysplasia.